Montelukast sodium

Molecular Structure of Montelukast sodium (CAS NO.151767-02-1):

IUPAC Name: sodium 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
Molecular Formula:C₃₅H₃₅ClNNaO₃S
Molecular Weight:608.17
H bond acceptors: 4
H bond donors: 2
Freely Rotating Bonds: 13
Polar Surface Area: 84.72 Å²
Flash Point: 407.7 °C
Enthalpy of Vaporization: 114.78 kJ/mol
Boiling Point: 750.5 °C at 760 mmHg
Vapour Pressure: 1.17E-23 mmHg at 25°C
InChI
InChI=1/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/q;+1/p-1/b15-10+;/t32-;/m1./s1
Smiles
C1(CC1)(CS[C@@H](c1cc(\C=C\c2nc3c(ccc(c3)Cl)cc2)ccc1)CCc1c(cccc1)C(C)(C)O)CC(=O)[O-].[Na+]
Product Categories: Active Pharmaceutical Ingredients; APIs; Chiral Reagents; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds;Isotope Labeled Compounds

 Montelukast sodium (CAS NO.151767-02-1) has side effect. Including  gastrointestinal disturbances, hypersensitivity reactions, sleep disorders and increased bleeding tendency and so on.

 Montelukast sodium , its cas register number is 151767-02-1. It also can be called Singulair ; montelukast na ; montelukast sodium ; 2-[1-[[1-[3-[2-[(7-chloro-2-quinolyl)]vinyl]phenyl]-3-[2-(1-hydroxy-1-methyl-ethyl)phenyl]-propyl]sulfanylmethyl]cyclopropyl]acetic acid sodium salt ; 1-[1-[[[(1r)-1-[3-[(1e)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic ; montelukast, sodium salt . Montelukast sodium (CAS NO.151767-02-1) is a selective leukotriene D4-receptor antagonist, can be used as an antiasthmatic treatment of asthma and to relieve symptoms of seasonal allergies.